Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03481881 · ClinicalTrials.gov registry record
Pharmacokinetics of Drugs Administered to Children
A clinical trial of Pediatric ALL, sponsored by Duke University.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT03481881: Recruiting study of Pediatric ALL, sponsored by Duke University.
NCT03481881 is a study of Pediatric ALL that is actively recruiting participants, run by Duke University. The registered enrollment target is 200 participants, below the 1,639-participant average among 21 other Pediatric ALL trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03481881, a study of Pediatric ALL, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective study of children \<21 years of age with the goal of characterizing the PK of drugs administered per standard of care as prescribed by the treating caregiver.
Conditions Studied
Interventions
- DRUG Standard of care drug
Study Locations (1)
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2013-08-14 |
| Est. Completion | 2033-08-14 |
What NCT03481881 shows while recruiting
NCT03481881 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,639-participant average among 21 other Pediatric ALL trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Pediatric ALL appearing as the primary indexed condition, and to 1 intervention - of which Standard of care drug is the first listed.
NCT03481881 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03481881 about?
NCT03481881 is a clinical study titled "Pharmacokinetics of Drugs Administered to Children". This is a prospective study of children \<21 years of age with the goal of characterizing the PK of drugs administered per standard of care as prescribed by the treating caregiver.
What is the current status of trial NCT03481881?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2013-08-14. Estimated completion is 2033-08-14.
What conditions does trial NCT03481881 study?
This clinical trial studies the following conditions: Pediatric ALL.
What interventions are being tested in trial NCT03481881?
The interventions under investigation include: Standard of care drug (DRUG).
Who is sponsoring clinical trial NCT03481881?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03481881 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric ALL
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03481881's enrollment target sits among peer trials
200 6th of 21 higher than 15 of 21 other Pediatric ALL trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pediatric ALL trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
RECRUITING · NA
-
PRotein Optimization With eXercise to Improve MUscle Mass and Functional outcomeS
RECRUITING · NA
-
Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
RECRUITING · Phase 1
-
Using Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy
RECRUITING · NA
-
Feasibility/Acceptability of Attentional-Control Training in Survivors
RECRUITING · NA
-
HEalth Advocate for Liver Transplant - Pilot
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI